# Commure

Commure is a healthcare technology company that applies artificial intelligence to medical records and clinical workflows, aiming to reduce administrative burden and improve patient care. It was founded in 2017 and is headquartered in San Francisco, California.

Commure is a healthcare technology company that develops software and artificial intelligence (AI) tools for medical records and clinical workflows. The company's products are designed to reduce administrative burden for clinicians, streamline data sharing across healthcare systems, and support decision-making through AI-powered insights. Commure operates primarily in the United States, with a focus on integrating its solutions into existing electronic health record (EHR) systems rather than replacing them entirely.

Founded in 2017, Commure emerged from the healthcare and technology sectors with the goal of modernizing the infrastructure that underpins patient data management. The company has positioned itself as a platform provider, offering tools that connect disparate healthcare data sources and apply machine learning to improve operational efficiency. Its name is derived from the Latin word 'commūnis,' meaning 'common' or 'shared,' reflecting its mission to create a more unified healthcare data ecosystem.

## Founding and Early Development

Commure was founded in 2017 by a team of engineers and healthcare professionals, including CEO Andrew Hines, who previously worked at companies such as Palantir Technologies and Google. The founding team identified a critical gap in healthcare: while EHR systems had digitized patient records, they remained fragmented, difficult to navigate, and burdensome for clinicians. Commure's initial product focused on creating a "universal API" for healthcare data, allowing different systems to communicate more seamlessly.

In its early years, Commure raised significant venture capital funding. In 2018, the company announced a $14 million Series A round led by General Catalyst, with participation from other investors. This funding supported the development of its core platform and early partnerships with academic medical centers. By 2019, Commure had begun piloting its technology at several hospitals, including those affiliated with major research universities.

## Core Products and Services

Commure's primary offerings include a suite of tools that operate alongside existing EHR systems. The company's flagship product, Commure OS, is a cloud-based platform that aggregates patient data from multiple sources, including lab results, imaging reports, and clinical notes. It uses natural language processing (NLP) and machine learning to organize this information into a more accessible format for physicians.

Another key product is Commure Engage, a patient-facing application that allows individuals to access their health records, schedule appointments, and communicate with providers. The app is designed to integrate with hospital systems, reducing friction in patient-provider interactions. Additionally, Commure offers analytics tools that help healthcare organizations identify trends in patient populations and optimize resource allocation.

In 2021, Commure introduced an AI-powered clinical documentation assistant that uses large language models (LLMs) to draft summaries of patient encounters. This tool listens to clinician-patient conversations and generates structured notes, aiming to reduce the time physicians spend on documentation. The assistant was developed in collaboration with healthcare providers and is designed to comply with privacy regulations such as the Health Insurance Portability and Accountability Act (HIPAA).

## Artificial Intelligence and Machine Learning

Commure's AI capabilities are built on a foundation of [machine-learning](https://www.wikiprompt.org/wiki/machine-learning) and [deep-learning](https://www.wikiprompt.org/wiki/deep-learning) techniques. The company employs [neural-network](https://www.wikiprompt.org/wiki/neural-network) models to process unstructured clinical text, such as physician notes and discharge summaries. These models are trained on de-identified patient data to recognize medical terminology, extract relevant information, and flag potential errors or omissions.

A significant focus for Commure is the use of [large-language-model](https://www.wikiprompt.org/wiki/large-language-model)s for clinical documentation and decision support. These models, similar in architecture to those developed by organizations like [openai](https://www.wikiprompt.org/wiki/openai) and [anthropic](https://www.wikiprompt.org/wiki/anthropic), are fine-tuned on healthcare-specific datasets. Commure's approach emphasizes transparency and clinician oversight, with AI-generated outputs requiring human review before being incorporated into medical records.

The company also applies [generative-ai](https://www.wikiprompt.org/wiki/generative-ai) to create patient education materials and simplify complex medical jargon. For example, Commure's platform can generate plain-language summaries of lab results or treatment plans, which are then shared with patients through its mobile app. This feature aims to improve health literacy and patient engagement.

## Partnerships and Integrations

Commure has established partnerships with several major healthcare organizations and technology providers. In 2020, the company announced a collaboration with [amazon-web-services](https://www.wikiprompt.org/wiki/amazon-web-services) (AWS) to host its cloud infrastructure, leveraging AWS's compliance certifications and scalability. This partnership allows Commure to offer its platform to health systems that require robust security and data residency controls.

In 2022, Commure partnered with [google-cloud](https://www.wikiprompt.org/wiki/google-cloud) to integrate its AI models with Google's healthcare APIs. This collaboration focused on improving interoperability between Commure's tools and Google's [artificial-intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) services, such as medical imaging analysis. The partnership also explored using [transformer](https://www.wikiprompt.org/wiki/transformer) architectures for more accurate clinical text processing.

Commure has also worked with academic institutions, including [mit-csail](https://www.wikiprompt.org/wiki/mit-csail) and [stanford-ai-lab](https://www.wikiprompt.org/wiki/stanford-ai-lab), to research AI applications in healthcare. These collaborations have produced studies on the accuracy of LLMs in clinical settings and the ethical implications of automating medical documentation. Commure's engineering team includes researchers who have published papers on topics such as model interpretability and bias mitigation.

## Regulatory and Privacy Considerations

Given the sensitive nature of health data, Commure places a strong emphasis on regulatory compliance. The company's products are designed to meet HIPAA standards, which govern the privacy and security of protected health information in the United States. Commure also adheres to the General Data Protection Regulation (GDPR) for its international operations, though its primary market remains the U.S.

In 2023, Commure received clearance from the U.S. Food and Drug Administration (FDA) for a component of its AI documentation tool, marking a milestone for the company. The clearance was for a software module that assists in coding clinical notes, a process that traditionally requires significant manual effort. This regulatory approval positioned Commure among a growing number of companies offering FDA-cleared AI solutions in healthcare.

## Market Position and Competition

Commure operates in a competitive landscape that includes established EHR vendors such as Epic Systems and Cerner, as well as emerging AI-focused startups. Unlike these larger incumbents, Commure does not seek to replace entire EHR systems but instead offers complementary tools that integrate with them. This strategy has attracted health systems looking to enhance their existing investments without undergoing costly migrations.

Competitors in the AI clinical documentation space include companies like Nuance Communications (acquired by Microsoft) and ambient intelligence startups such as Abridge and Suki. Commure differentiates itself through its focus on data interoperability and its partnerships with cloud providers. The company also emphasizes clinician feedback in its product development, conducting regular usability studies with physicians and nurses.

As of 2024, Commure had raised over $100 million in total funding, with investors including General Catalyst, Mayo Clinic, and other healthcare-focused venture funds. The company reported that its platform was deployed at more than 50 health systems across the U.S., serving over 10,000 clinicians. These figures reflect steady growth, though Commure remains smaller than major EHR vendors.

## Future Directions

Looking ahead, Commure plans to expand its AI capabilities to include predictive analytics for patient outcomes and population health management. The company is exploring the use of [deep-learning](https://www.wikiprompt.org/wiki/deep-learning) models to identify patients at risk of readmission or complications, allowing providers to intervene earlier. These efforts are part of a broader trend toward precision medicine, where AI helps tailor treatments to individual patient characteristics.

Commure is also investing in research on [artificial-intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) safety and fairness. The company has published guidelines for auditing AI models in healthcare, emphasizing the need to detect and mitigate biases related to race, gender, and socioeconomic status. This work aligns with initiatives from academic groups like [berkeley-ai-research](https://www.wikiprompt.org/wiki/berkeley-ai-research) and [carnegie-mellon-university](https://www.wikiprompt.org/wiki/carnegie-mellon-university), which study responsible AI development.

The company has not disclosed plans for an initial public offering, but its leadership has indicated a desire to scale its operations internationally. Commure's headquarters remain in San Francisco, California, with additional offices in Boston and New York. As healthcare systems continue to adopt digital tools, Commure aims to play a central role in making medical records more intelligent and accessible.

## Leadership and Culture

Commure's leadership team includes CEO Andrew Hines, who has a background in data science and healthcare entrepreneurship. Chief Technology Officer Ani Bhattacharya, who joined in 2019, previously led engineering teams at [intuitive-surgical](https://www.wikiprompt.org/wiki/intuitive-surgical) and other medical device companies. The company's culture emphasizes interdisciplinary collaboration, with engineers, clinicians, and product designers working together on each feature.

Commure has been recognized for its workplace practices, appearing on lists of top healthcare startups in publications such as Forbes and Fast Company. The company maintains a hybrid work model, with employees splitting time between offices and remote work. It also runs a fellowship program for early-career researchers, partnering with universities to mentor students interested in AI and healthcare.

## Conclusion

Commure represents a notable example of how [artificial-intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) is being applied to the complex domain of medical records. By focusing on interoperability, clinician usability, and regulatory compliance, the company has carved out a niche in the healthcare technology market. While it faces competition from larger incumbents and nimble startups, its partnerships and AI-driven products position it for continued growth. As of 2025, Commure continues to evolve, with ongoing research and development aimed at improving patient care through intelligent data management.

---
Source: https://www.wikiprompt.org/wiki/commure
License: CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/)
Last updated: 2026-09-05T13:21:54.979632+00:00